multipl
sclerosi
ms
chronic
inflammatori
diseas
central
nervou
system
cn
one
common
neurolog
diseas
young
adult
develop
countri
hallmark
diseas
focal
plaqu
demyelin
white
matter
cn
evid
autoimmun
process
diseas
mostli
circumstanti
first
autoreact
cell
found
blood
patient
yet
point
role
cell
diseas
process
sinc
cn
antigenspecif
cell
also
normal
compon
immun
system
healthi
individu
howev
experi
anim
model
autoimmun
encephalomyel
clearli
demonstr
cell
initi
cn
inflamm
activ
second
autoreact
cell
antibodi
found
ms
lesion
immunotherapi
target
cn
antigenspecif
cell
may
delay
amelior
diseas
progress
ms
patient
howev
situat
much
complex
date
ms
specif
autoimmun
respons
describ
trigger
might
set
maintain
autoimmun
chronic
diseas
cours
last
year
decad
remain
unknown
autoimmun
respons
cn
ms
patient
invari
detriment
may
even
benefici
final
diffus
alter
indic
gener
neurodegen
process
present
throughout
brain
mani
ms
patient
alter
necessarili
due
immunemedi
mechan
henc
still
mani
gap
fill
autoimmun
hypothesi
ms
ms
one
common
neurolog
diseas
within
develop
countri
usual
start
young
adult
lead
chronic
relaps
progress
cours
mani
year
major
neurolog
disabl
noseworthi
et
al
genet
factor
import
determin
suscept
develop
diseas
within
famili
ms
patient
mendelian
pattern
inherit
found
kalman
lublin
furthermor
studi
ident
twin
show
addit
genet
factor
pathogenet
trigger
involv
diseas
induct
suspect
infect
may
act
trigger
diseas
far
ms
specif
agent
identifi
ms
believ
autoimmun
diseas
sinc
part
amelior
control
immunosuppress
immunomodulatori
treatment
sinc
autoreact
lymphocyt
antibodi
found
patient
wekerl
noseworthi
et
al
furthermor
chronic
inflammatori
demyelin
diseas
close
similar
ms
induc
mani
differ
anim
speci
activ
sensit
brain
tissu
specif
brain
antigen
wekerl
howev
concept
autoimmun
ms
question
frequent
sinc
uniqu
msspecif
autoimmun
respons
identifi
date
addit
recent
studi
show
diseas
process
ms
much
complex
previous
thought
includ
interindividu
heterogen
pathogenet
mechan
lesion
format
presenc
chronic
neurodegen
compon
unknown
relat
immunemedi
process
owen
chapter
summar
current
knowledg
immunolog
immunopatholog
ms
discuss
argument
autoimmun
hypothesi
ms
clinic
cours
ms
highli
unpredict
noseworthi
et
al
rang
benign
diseas
patient
suffer
relaps
without
develop
perman
clinic
deficit
acut
fulmin
cours
lead
death
patient
within
month
diseas
onset
patient
diseas
start
relaps
cours
character
episod
exacerb
follow
remiss
recoveri
relapsingremit
multipl
sclerosi
rrm
sever
year
relaps
cours
develop
diseas
steadi
uninterrupt
increas
neurolog
disabl
socal
secondari
progress
cours
diseas
secondari
progress
multipl
sclerosi
spm
patient
relaps
phase
diseas
miss
patient
follow
progress
cours
onset
diseas
form
ms
call
primari
progress
ms
ppm
use
magnet
reson
imag
follow
lesion
develop
differ
phase
ms
shown
relaps
phase
diseas
new
lesion
appear
brain
associ
bloodbrain
barrier
damag
wer
et
al
suggest
lesion
trigger
new
wave
inflammatori
cell
reach
cn
tissu
circul
passag
cerebr
vessel
mark
contrast
situat
progress
phase
diseas
spm
ppm
new
lesion
rare
form
brain
white
matter
bloodbrain
barrier
damag
detect
instead
profound
abnorm
found
socal
normal
white
matter
suggest
diffus
injuri
affect
brain
whole
diffus
chang
alreadi
seen
earli
stage
rrm
seem
gradual
increas
time
filippi
et
al
patholog
ms
defin
inflammatori
demyelin
diseas
lassmann
et
al
sinc
focal
plaqu
primari
demyelin
rel
axon
spare
reactiv
astrogli
scare
form
cours
chronic
inflammatori
reaction
inflammatori
infiltr
mainli
compos
lymphocyt
activ
macrophag
microglia
cell
within
lymphocyt
popul
chronic
inflammatori
lesion
mhc
class
irestrict
cell
domin
gay
et
al
addit
promin
chronic
progress
stage
diseas
b
lymphocyt
plasma
cell
accumul
mainli
mening
perivascular
space
b
cell
plasma
cell
respons
continu
intrathec
product
immunoglobulin
format
new
activ
demyelin
plaqu
white
matter
figur
mainli
found
relaps
stage
diseas
process
associ
pronounc
inflammatori
infiltr
whole
tissu
accompani
profound
bloodbrain
barrier
disturb
structur
immunopatholog
featur
activ
ms
plaqu
differ
differ
patient
subpopul
suggest
interindividu
heterogen
mechan
tissu
damag
patient
demyelin
tissu
injuri
mainli
associ
cytotox
cell
activ
macrophagesmicroglia
cell
other
immunoglobulin
activ
complement
deposit
site
activ
myelin
destruct
anoth
subgroup
patient
pattern
tissu
damag
close
resembl
hypox
tissu
injuri
furthermor
small
cohort
patient
show
unusu
sever
damag
myelin
oligodendrocyt
andor
axon
suggest
problem
target
tissu
cope
inflammatori
insult
contrast
relaps
stage
diseas
format
new
activ
white
matter
lesion
rare
progress
diseas
typic
find
slow
gradual
enlarg
preexist
plaqu
prinea
et
al
addit
mild
complet
diffus
inflammatori
process
whole
brain
mening
evid
associ
diffus
microglia
activ
ongo
axon
injuri
normal
white
matter
format
larg
area
cortic
demyelin
kidd
et
al
topic
relat
inflammatori
process
mening
clear
yet
whether
diffus
inflammatori
process
caus
global
cortic
white
matter
damag
progress
ms
whether
occur
secondari
reaction
degen
process
brain
clear
evid
immun
reaction
direct
cn
myelin
neuron
glia
cell
ie
autoimmun
reaction
ms
patient
sinc
ms
inflammatori
demyelin
diseas
least
northern
europ
often
associ
express
mhc
class
ii
antigen
search
autoimmun
mainli
search
myelin
antigen
possibl
recogn
braininfiltr
mhc
class
iirestrict
cell
inde
cell
specif
recogn
myelin
basic
protein
mbp
proteolipid
protein
plp
myelin
oligodendrocyt
glycoprotein
mog
pett
et
al
kerlero
de
rosbo
et
al
could
readili
isol
blood
ms
patient
howev
cell
isol
blood
healthi
individu
well
indic
normal
compon
immun
system
wekerl
search
quantit
differ
olsson
et
al
antimyelin
respons
lymphocyt
found
blood
ms
patient
healthi
control
simpl
assay
test
primari
prolifer
respons
turn
insuffici
sensit
detect
differ
except
singl
studi
show
stronger
prolif
respons
mog
ms
patient
control
kerlero
de
rosbo
et
al
sensit
approach
use
elispot
techniqu
prove
reward
point
increas
cell
respons
also
plp
mbp
olsson
et
al
qualit
differ
antimyelin
respons
becam
focu
intens
research
observ
monozygot
twin
differ
antimbp
respons
twin
develop
ms
similar
epitop
recognit
pattern
one
twin
ms
differ
epitop
recognit
utz
et
al
studi
reveal
autoimmun
respons
mbp
focus
narrow
domin
peptid
segment
select
patientsa
find
contrast
broad
peptid
recognit
pattern
control
narrow
epitop
pattern
may
remark
stabl
sever
year
cours
diseas
howev
patient
epitop
recognit
pattern
radic
chang
time
best
demonstr
human
patient
progress
isol
monosymptomat
demyelin
syndrom
imd
clinic
definit
ms
tuohi
et
al
coincid
appear
soon
diagnosi
imd
plpspecif
cell
patient
recogn
singl
specif
plp
peptid
cours
diseas
respons
peptid
regress
respons
plp
epitop
emerg
chang
cell
reactiv
concur
relaps
diagnosi
clinic
definit
ms
normal
circumst
cn
antigenspecif
cell
rest
compon
immun
system
howev
activ
trigger
autoimmun
reaction
within
human
cn
evid
diseas
scenario
come
seri
neuroparalyt
accid
human
receiv
antirabi
treatment
kill
carbol
viru
isol
infect
anim
brain
sinc
vaccin
contamin
brain
materi
cn
antigenspecif
cell
treat
patient
activ
initi
cn
inflamm
review
see
bradl
hohlfeld
discoveri
pave
way
develop
experiment
autoimmun
encephalomyel
eae
anim
model
wide
use
deciph
certain
aspect
cn
inflamm
demyelin
seen
ms
patient
base
anim
model
undisput
activ
cell
recogn
antigen
myelin
oligodendrocyt
astrocyt
well
neuron
induc
inflammatori
brain
diseas
berger
et
al
howev
becam
also
clear
everi
activ
cn
antigenspecif
cell
autoaggress
henc
pathogen
exampl
mice
harbor
plpspecif
cell
immun
repertoir
activ
cell
immun
plp
fail
provok
cn
inflamm
mark
contrast
situat
sjl
mice
treatment
regimen
plpspecif
cell
anim
initi
massiv
inflammatori
lesion
cn
differ
two
strain
mice
ascrib
variat
intrathym
express
tissuespecif
selfantigen
toler
induct
klein
et
al
anoth
exampl
provid
mogreact
cell
line
isol
lewi
rat
cell
line
vigor
prolifer
respons
specif
peptid
cell
reactiv
mog
mog
encephalitogen
henc
abl
induc
cn
inflamm
cell
specif
mog
incap
mediat
inflammatori
respons
within
cn
adelmann
et
al
base
inform
report
presenc
expans
prolifer
myelinspecif
cell
repertoir
ms
patient
critic
evalu
long
encephalitogen
potenti
describ
cell
remain
unclear
attempt
clarifi
issu
human
myelinspecif
cell
transfer
scid
mice
rhesu
monkey
result
studi
inconclus
review
see
bradl
around
time
human
mous
model
creat
use
transgen
anim
express
three
human
compon
involv
cell
recognit
cell
receptor
deriv
mbpspecif
cell
clone
ms
patient
recogn
mbp
epitop
conserv
mous
man
b
mhc
class
ii
antigen
associ
ms
c
human
coreceptor
human
mbpspecif
cell
anim
activ
cn
inflamm
ensu
madsen
et
al
seen
turn
extrem
difficult
prove
myelinspecif
cell
found
immun
repertoir
ms
patient
directli
involv
initi
andor
progress
autoimmun
reaction
within
cn
group
use
vivo
approach
solv
problem
instead
concentr
inflammatori
lesion
ms
patient
reason
abl
find
cn
antigenspecif
cell
plaqu
provid
lesion
initi
cell
inde
character
cell
receptor
usag
cell
found
ms
plaqu
reveal
presenc
cell
similar
complementarydetermin
sequenc
found
mbpreactiv
cell
line
oksenberg
et
al
addit
mbpmhc
class
ii
complex
found
antigenpres
cell
within
ms
plaqu
indic
mbp
epitop
could
present
local
antigenpres
cell
krogsgaard
et
al
taken
togeth
sever
report
describ
presenc
reactivityreceptor
usag
myelinspecif
cell
ms
patient
recent
search
medlin
reveal
entri
littl
evid
activ
role
cn
antigenspecif
cell
induct
ms
see
even
less
known
domin
cell
popul
ms
plaqu
cell
accord
recent
public
cell
ms
lesion
repres
oligoclon
popul
babb
et
al
cell
enrich
site
activ
demyelin
lesion
evid
direct
cytotox
interact
lymphocyt
target
cell
cn
neumann
et
al
howev
remain
unclear
whether
cell
actual
recogn
myelin
protein
mount
autoimmun
respons
cn
antigen
whether
recogn
probabl
viral
target
structur
situat
complic
fact
studi
avail
far
show
class
irestrict
myelinspecif
cell
induc
brain
inflamm
experiment
anim
husebi
et
al
sun
et
al
unfortun
model
develop
extent
valid
model
ms
judg
moreov
cnsspecif
protein
even
glycolipid
de
libero
may
target
encephalitogen
autoreact
cell
henc
cellmedi
autoimmun
ms
patient
may
direct
mani
differ
cn
antigen
may
differ
individu
patient
may
thu
surpris
common
msspecif
autoimmun
respons
far
identifi
doubt
chronic
b
cell
respons
persist
immunoglobulin
product
cn
ms
patient
best
exemplifi
diagnost
use
determin
intrathec
immunoglobulin
synthesi
presenc
oligoclon
immunoglobulin
cerebrospin
fluid
recent
studi
use
new
molecular
technolog
show
extens
somat
mutat
immunoglobulin
variabl
gene
b
cell
isol
lesion
cerebrospin
fluid
affect
patient
owen
et
al
qin
et
al
data
also
suggest
b
cell
plasma
cell
popul
brain
ms
patient
deriv
expans
individu
b
cell
clone
possibl
driven
local
antigen
stimul
antibodi
synthes
intrathec
b
cell
popul
direct
autoantigen
question
still
unresolv
sinc
detail
studi
aim
defin
antigen
specif
oligoclon
immunoglobulin
ms
patient
far
inconclus
nevertheless
antibodi
circul
cerebrospin
fluid
csf
ms
patient
may
direct
larg
number
differ
autoantigen
archelo
hartung
extens
studi
antibodi
mbp
mog
berger
et
al
found
higher
frequenc
ms
patient
control
serum
titer
time
first
clinic
present
may
predict
fast
diseas
convert
definit
ms
howev
presenc
antibodi
mog
mbp
uniqu
ms
patient
also
found
patient
inflammatori
noninflammatori
cn
diseas
henc
antibodi
may
rather
repres
secondari
respons
immun
system
brain
damag
rather
pathogen
evid
pathogen
autoantibodi
respons
induct
demyelin
tissu
injuri
one
requir
autoantibodi
directli
pathogen
target
antigen
access
intact
tissu
thu
respect
target
antigen
locat
either
cell
surfac
extracellular
matrix
compon
contrast
antibodi
detect
ms
patient
reactiv
intracellular
antigen
mbp
neurofila
situat
differ
mog
small
immunoglobulinlik
molecul
express
surfac
myelin
sheath
oligodendrocyt
linington
et
al
antimog
antibodi
detect
ms
patient
pathogenet
irrelev
sinc
direct
linear
epitop
hidden
within
fold
molecular
structur
brehm
et
al
howev
small
subgroup
ms
patient
antibodi
recogn
conform
epitop
mog
access
surfac
intact
oligodendrocyt
haas
et
al
myelin
sheath
sinc
antibodi
drive
demyelin
anim
model
eae
linington
et
al
like
also
truli
pathogen
human
lead
antibodyand
complementmedi
demyelin
characterist
found
activ
lesion
subset
ms
patient
antibodi
may
pathogenet
relev
direct
surfac
molecul
express
glial
progenitor
cell
niehau
et
al
antibodi
found
subset
ms
patient
sinc
antibodi
may
initi
destruct
glial
progenitor
cell
could
respons
failur
myelin
repair
patient
taken
togeth
autoantibodi
direct
cell
surfac
antigen
cn
cell
compon
extracellular
matrix
brain
potenti
pathogen
ms
target
structur
antibodi
may
vari
individu
patient
common
msspecif
autoantibodi
describ
yet
describ
strong
alway
indirect
evid
immunopathogenesi
ms
figur
differ
autoimmun
mechan
might
oper
differ
patient
differ
stage
diseas
sever
immunotherapi
provid
evid
presenc
autoimmun
reaction
ms
patient
particular
level
mbpspecif
lymphocyt
exampl
mbpreactiv
cell
suspect
involv
pathogenesi
ms
deplet
subcutan
inocul
irradi
autolog
mbpreactiv
cell
cell
vaccin
treatment
regimen
result
induct
cell
specif
suppress
mbpreactiv
cell
zang
et
al
led
least
observ
interv
month
reduct
relaps
rate
compar
pretreat
rate
stabil
lesion
activ
zhang
et
al
immunotherapi
use
alter
peptid
ligand
mbp
ms
patient
studi
cell
recogn
put
target
epitop
autoimmun
respons
mbp
target
peptid
differ
peptid
normal
recogn
one
two
amino
acid
hope
modul
cell
respons
nativ
peptid
antigen
outcom
trial
inconclus
one
group
describ
induct
regulatori
type
helper
cell
reduct
volum
number
lesion
kappo
et
al
anoth
group
found
exacerb
ms
directli
link
activ
mbpspecif
cell
subgroup
patient
bielekova
et
al
sum
immunotherapi
provid
evid
role
myelinspecif
cell
diseas
howev
evid
cell
directli
involv
initi
ms
studi
describ
clearli
shown
autoimmun
reaction
occur
appear
abund
pronounc
ms
patient
compar
control
furthermor
studi
indic
ms
may
associ
increas
risk
develop
autoimmun
diseas
henderson
et
al
trigger
autoimmun
reaction
ms
patient
small
number
transgen
mice
carri
expand
popul
encephalitogen
cell
immun
repertoir
spontan
develop
eae
howev
lymphocyt
genet
ablat
diseas
incid
increas
lafail
et
al
data
point
presenc
regulatori
cell
immun
system
may
prevent
termin
autoimmun
reaction
ms
patient
immuneregulatori
process
might
act
least
two
earli
studi
show
reduc
suppressor
activ
peripher
leucocyt
ms
patient
activ
diseas
antel
et
al
relat
reduc
number
cell
circul
reinherz
et
al
implic
suppressor
cell
might
play
major
role
regul
relaps
remit
cours
ms
howev
subsequ
studi
found
much
less
clearcut
correl
diseas
activ
loss
suppressor
function
antel
et
al
chang
peripher
cell
number
hugh
et
al
reduc
number
cell
put
regulatori
function
observ
within
inflammatori
infiltr
ms
lesion
also
suggest
defect
termin
local
immun
respons
et
al
global
defect
immun
regul
ms
patient
postul
follow
observ
number
regulatori
high
cell
circul
ms
patient
lower
control
viglietta
et
al
possibl
provok
impair
releas
cell
thymu
hug
et
al
find
typic
ms
patient
sinc
anoth
studi
fail
detect
differ
putheti
et
al
final
low
incid
asthma
ms
patient
tramlett
et
al
suggest
gener
bia
immun
respons
toward
cell
cytotox
lymphocyt
polar
product
cytokin
inde
therapeut
strategi
believ
shift
immun
respons
reaction
show
benefici
effect
particular
patient
acut
relaps
diseas
neuhau
et
al
taken
togeth
studi
address
question
possibl
regulatori
defect
ms
patient
result
studi
present
far
conclus
henc
concept
gener
defect
immun
regul
ms
patient
remain
attract
hypothesi
proven
futur
largescal
clinic
studi
base
extens
studi
becam
clear
chronic
inflammatori
demyelin
diseas
reminisc
ms
induc
experiment
anim
sever
differ
virus
caus
exampl
theiler
virusinduc
encephalomyel
drescher
et
al
corona
virusinduc
demyelin
enceph
nagashima
et
al
canin
distemp
viru
enceph
summer
appel
model
diseas
start
panenceph
affect
gray
white
matter
lead
injuri
glia
cell
neuron
infect
gradual
clear
cn
gray
matter
may
persist
white
matter
may
caus
slowli
progress
inflammatori
demyelin
diseas
culmin
format
focal
plaqu
demyelin
dethlef
et
al
tissu
damag
mediat
cell
class
irestrict
cell
appear
particularli
import
induct
axon
damag
clinic
deficit
cell
popul
seem
involv
induct
progress
demyelin
murray
et
al
import
lesson
anim
model
viral
infect
induc
autoimmun
reaction
compon
cn
tissu
may
involv
propag
chronic
diseas
possibl
antigen
determin
spread
croxford
et
al
implic
contribut
autoimmun
cell
chronic
inflammatori
reaction
induct
tissu
injuri
sinc
viru
complet
elimin
cn
experiment
anim
remain
unclear
whether
virusinduc
autoimmun
alon
absenc
viral
persist
cn
could
maintain
longlast
chronic
inflammatori
demyelin
diseas
littl
doubt
infect
unusu
precursor
onset
ms
frequent
preced
relaps
progress
ms
moreov
oligoclon
igg
band
csf
diagnost
hallmark
ms
otherwis
almost
exclus
found
infecti
diseas
nervou
system
eg
mump
mening
neurosyphili
cryptococc
mening
subacut
scleros
panenceph
chronic
rubella
panenceph
gilden
infect
trigger
autoimmun
reaction
stress
reaction
associ
infect
lead
reactiv
human
virus
site
latenc
cn
may
turn
start
immun
reaction
direct
viral
structur
research
program
address
scenario
first
line
research
follow
observ
transgen
mice
carri
murin
encephalitogen
cell
receptor
fact
anim
remain
healthi
kept
specif
pathogenfre
condit
develop
spontan
cn
inflamm
live
normal
environ
goverman
et
al
led
suggest
activ
cell
entri
cn
may
result
action
recognit
bacterialvir
protein
similar
system
trigger
also
postul
patient
earli
relapsingremit
ms
sinc
lesion
appear
concurr
brain
spinal
cord
thorp
et
al
clear
evid
activ
cn
antigenspecif
cell
infecti
agent
came
pioneer
work
wucherpfennig
stroming
demonstr
mbpspecif
cell
clone
deriv
ms
patient
activ
peptid
deriv
herp
simplex
viru
epsteinbarr
viru
influenza
viru
pseudomonasand
list
viral
bacteri
peptid
increas
ever
sinc
hemmer
et
al
second
line
research
stimul
isol
msassoci
retroviru
choroid
plexu
b
lymphocyt
ms
patient
perron
et
al
viru
relat
novel
famili
human
endogen
retrovirus
human
endogen
retroviru
type
w
hervw
perron
et
al
complet
hervw
proviru
present
chromosom
region
associ
suscept
ms
charmley
et
al
recent
detect
hervw
retrovir
antigen
neuron
axon
endotheli
cell
activ
ms
lesion
unpublish
observ
howev
express
inact
lesion
low
absent
determin
futur
whether
viru
activ
respons
stress
environ
ms
lesion
whether
immun
respons
retrovirus
caus
develop
ms
andor
propag
lesion
thu
attract
viralbacteri
trigger
autoimmun
reaction
ms
patient
may
known
infect
provok
onset
diseas
autoreact
cell
autoantibodi
direct
compon
cn
part
normal
immun
repertoir
sinc
mbpspecif
cell
also
activ
viralbacteri
peptid
respons
peptid
might
high
even
higher
respons
mbp
wucherpfennig
stroming
seem
fair
assum
risk
develop
autoimmun
diseas
price
pay
effici
fast
immun
respons
pathogen
moreov
inflamm
alway
consid
undesir
reaction
fact
research
anim
model
traumat
excitotox
brain
lesion
convincingli
demonstr
inflammatori
cell
may
serv
benefici
function
limit
tissu
injuri
stimul
tissu
repair
observ
even
led
concept
protect
autoimmun
moalem
et
al
activ
lymphocyt
macrophag
potent
sourc
growth
factor
neurotrophin
moalem
et
al
eg
brainderiv
neurotroph
factor
bdnf
abl
rescu
neuron
vitro
kerschenstein
et
al
interestingli
neuron
glia
cell
activ
edg
demyelin
inflammatori
ms
lesion
express
receptor
bdnf
stadelmann
et
al
moreov
leukocytederiv
neurotrophin
also
essenti
recruit
oligodendrocyt
progenitor
cell
induct
remyelin
franklin
protect
autoimmun
featur
selfantigenspecif
cell
also
observ
autoantibodi
exampl
murin
human
antibodi
igm
isotyp
recogn
antigen
surfac
oligodendrocyt
may
promot
remyelin
cn
asakura
et
al
observ
point
concern
extens
immunosuppress
ms
patient
plan
treatment
could
reduc
limit
possibl
deleteri
consequ
cn
inflamm
could
also
impair
remyelin
repair
data
discuss
seem
ms
patient
one
featur
common
share
presenc
autoreact
cell
immun
repertoir
howev
share
healthi
subject
well
featur
diseas
seem
rather
patientspecif
trigger
diseas
diseas
cours
patholog
characterist
ms
plaqu
contribut
immun
system
patholog
chang
cn
auto
antigen
recogn
cell
andor
antibodi
even
respons
treatment
evid
autoimmun
process
could
involv
everi
singl
aspect
mention
bring
aspect
togeth
uniform
pictur
ms
remain
challeng
futur
